ADHD prescriptions continue to rise as age and sex differences seen in diagnostic rates

ADHD prescriptions in England have increased by 12% in the first quarter of 2026, with a notable rise in diagnosed patients and a higher proportion of female patients compared to previous years. The data highlights significant gender differences, with males more likely to be diagnosed in the 5–19 age group, while females outnumber males in older age groups. Experts emphasize the need for improved recognition of ADHD in girls and women, as well as a balanced approach to treatment that includes diagnosis, lifestyle support, and medication when necessary.

Read at The Pharmaceutical Journal

All articles from 15 September 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.